We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Adeia
ADEA
$3.16B
| $5.55M | 0.01% |
1,113,826
-155,449
| -12% | -$837K |
|
|
SAFE
1302
Safehold
SAFE
$1.1B
| $5.55M | 0.01% |
45,465
-6,643
| -13% | -$801K |
|
1303
ESCO Technologies
ESE
$7.79B
| $5.55M | 0.01% |
72,023
-10,343
| -13% | -$915K |
|
1304
Brinker International
EAT
$10.2B
| $5.53M | 0.01% |
112,765
-18,607
| -14% | -$1.01M |
|
1305
Sprout Social
SPT
$604M
| $5.53M | 0.01% |
45,302
+1,950
| +4% | +$212K |
|
1306
Axalta
AXTA
$7.93B
| $5.51M | 0.01% |
188,857
-16,084
| -8% | -$481K |
|
|
CVSA
1307
Covista Inc
CVSA
$4.49B
| $5.48M | 0.01% |
144,958
-13,011
| -8% | -$483K |
|
1308
Vericel Corp
VCEL
$2.28B
| $5.48M | 0.01% |
112,296
-17,168
| -13% | -$889K |
|
1309
U-Haul Holding Co
UHAL
$14.4B
| $5.47M | 0.01% |
84,680
-6,890
| -8% | -$432K |
|
1310
Federal Signal
FSS
$7.51B
| $5.47M | 0.01% |
141,594
-23,371
| -14% | -$919K |
|
1311
Upwork
UPWK
$1.08B
| $5.47M | 0.01% |
121,440
+1,495
| +1% | +$72.9K |
|
1312
Banner Corp
BANR
$2.5B
| $5.46M | 0.01% |
98,926
-13,664
| -12% | -$736K |
|
1313
B&G Foods
BGS
$299M
| $5.45M | 0.01% |
182,445
-25,425
| -12% | -$763K |
|
1314
Twist Bioscience
TWST
$7.86B
| $5.45M | 0.01% |
50,931
+1,183
| +2% | +$135K |
|
1315
Fate Therapeutics
FATE
$294M
| $5.43M | 0.01% |
91,673
+2,109
| +2% | +$165K |
|
|
IRBT
1316
DELISTED
iRobot
IRBT
| $5.43M | 0.01% |
69,158
-10,854
| -14% | -$925K |
|
|
SUM
1317
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $5.42M | 0.01% |
172,325
+4,123
| +2% | +$135K |
|
1318
Forward Air
FWRD
$682M
| $5.42M | 0.01% |
65,223
-11,043
| -14% | -$966K |
|
1319
Apple Hospitality REIT
APLE
$3.75B
| $5.41M | 0.01% |
343,923
+9,988
| +3% | +$150K |
|
1320
Strategy Inc
MSTR
$38.2B
| $5.39M | 0.01% |
93,190
-130,490
| -58% | -$8.37M |
|
1321
APi Group
APG
$18.8B
| $5.38M | 0.01% |
396,749
+27,344
| +7% | +$396K |
|
1322
Freshpet
FRPT
$3.5B
| $5.38M | 0.01% |
37,719
-16
| -0% | -$2.29K |
|
|
VBTX
1323
DELISTED
Veritex Holdings
VBTX
| $5.38M | 0.01% |
136,740
-19,248
| -12% | -$670K |
|
1324
Acadia Realty Trust
AKR
$2.86B
| $5.37M | 0.01% |
263,017
-30,093
| -10% | -$634K |
|
1325
Progress Software
PRGS
$1.83B
| $5.35M | 0.01% |
108,721
-18,758
| -15% | -$863K |
|
Similar funds
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.